Please assess the completion status of the following clinical trial:

Trial Title: PMC Split Preparation for Colon Cleansing

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult outpatients~* aged 18-85 yr~* undergoing elective colonoscopy~Exclusion Criteria:~* previous colon resection,~* ileus,~* intestinal obstruction,~* toxic megacolon,~* severe heart failure (NYHA Class III or IV),~* acute cardiovascular disease,~* uncontrolled arterial hypertension (systolic pressure \>170 mmHg, diastolic pressure \>100 mmHg),~* severe liver cirrhosis (Child-Pugh score C),~* renal failure (creatinine clearance\<30 mL/minute),~* ascites,~* phenylketonuria,~* glucose-6-phosphate dehydrogenase deficiency,~* pregnant or breastfeeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Group A: standard regimen (Type: ACTIVE_COMPARATOR): Patients in the group A (standard regimen) will be instructed to take the two sachets of sodium picosulphate/magnesium citrate diluted in a glass of water 2-4 hours apart, starting at 5 pm the day before colonoscopy.
- Group B (Type: ACTIVE_COMPARATOR): Patients in the group B (split regimen) will be instructed to take the first sachet of sodium picosulphate/magnesium citrate at 7 pm the day before colonoscopy and the second one at 6 am in the morning on the day of colonoscopy.

Based on this trial design, predict the completion outcome and termination type (if applicable).